Document Detail


Clinical experience of granulocyte transfusion in the management of neutropenic patients with haematological malignancies and severe infection.
MedLine Citation:
PMID:  22992038     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
Background: Prolonged chemotherapy-induced neutropenia is a major risk factor for the development of severe bacterial and fungal infections. Infectious manifestations may progress despite adequate anti-infectious treatment and lead to a very high short-term mortality. Granulocyte transfusion (GT) therapy is often considered. However, its efficacy is not well documented. Methods: We retrospectively analyzed the clinical characteristics and outcome of a cohort of patients with haematological malignancies receiving GT during neutropenia and severe infection. Results: A total of 30 patients with a median age of 46 y (range 3-82 y) who had received 1 or more GT were included. Acute leukaemia (80%) and non-Hodgkin lymphoma (17%) predominated as the underlying malignancy. All patients had severe and prolonged (median 16 days) neutropenia. The major indications for GT were persistent fever and clinical deterioration despite broad anti-infectious therapy, in combination with progressive pneumonia (n = 16), neutropenic enterocolitis (n = 6), and soft tissue infections (n = 3). GTs were given for a median of 3 transfusions (range 1-14). The median time to fever defervescence after GT was 14 days (range 6-33 days). For 11 patients, the resolution of fever and all signs of infection could directly be related to GT, and 3 of these patients became long-term survivors. Mortality at 30 days post-GT was 40% and at 6 months post-GT was 72%. GT was well tolerated. Conclusions: A substantial proportion of severely ill neutropenic patients appeared to benefit from GT. The results further underline the need for well- designed, randomized, prospective trials to determine the efficacy of this intervention in patients with life-threatening infectious complications.
Authors:
Honar Cherif; Ulla Axdorph; Mats Kalin; Magnus Björkholm
Related Documents :
24311548 - Leptospirosis and dengue fever: a predictive model for early differentiation based on c...
20524578 - Inhaled triamcinolone with proton pump inhibitor for treatment of vocal process granulo...
14714128 - Health status and voice outcome after treatment for t1a glottic carcinoma.
17768548 - Intermittent exotropia: comparative surgical results of lateral recti-recession and mon...
15836848 - Utility of acellular allograft dermis in the care of elderly burn patients.
22783518 - Fabrication of stable cartilage framework for microtia in incomplete synchondrosis.
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2012-9-19
Journal Detail:
Title:  Scandinavian journal of infectious diseases     Volume:  -     ISSN:  1651-1980     ISO Abbreviation:  Scand. J. Infect. Dis.     Publication Date:  2012 Sep 
Date Detail:
Created Date:  2012-9-20     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0215333     Medline TA:  Scand J Infect Dis     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Affiliation:
Department of Haematology, Uppsala University Hospital , Uppsala.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Integrating ligand-based and protein-centric virtual screening of kinase inhibitors using ensembles ...
Next Document:  Physiologically based kinetic (PBK) models for the alkenylbenzene elemicin in rat and human and poss...